The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Neuroblastoma and MYCN
Open accessAbstract
Neuroblastoma, the most common extracranial solid tumor of childhood, is thought to originate from undifferentiated neural crest cells. Amplification of the MYC family member, MYCN, is found in ∼25% of cases and correlates with high-risk disease and poor prognosis. Currently, amplification of MYCN remains the best-characterized genetic marker of risk in neuroblastoma. This article reviews roles for MYCN in neuroblastoma and highlights recent identification of other driver mutations. Strategies to target MYCN at the level of protein stability and transcription are also reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., & Bishop, J. M. (1984) · Science · doi:10.1126/science.6719137 · Cited by 2,262
Association of Multiple Copies of the N-myc Oncogene with Rapid Progression of Neuroblastomas
Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., & Hammond, D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510313131802 · Cited by 2,010
St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2012) · Nature Genetics · doi:10.1038/ng.1102 · Cited by 1,724
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Identification of ALK as a major familial neuroblastoma predisposition gene
Mossé, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., Laquaglia, M. J., Sennett, R., Lynch, J. E., Perri, P., et al. (2008) · Nature · doi:10.1038/nature07261 · Cited by 1,407
Schwab, M., Alitalo, K., Klempnauer, K.-H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M., & Trent, J. (1983) · Nature · doi:10.1038/305245a0 · Cited by 1,407
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,393
Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,336
The genetic landscape of high-risk neuroblastoma
Pugh, T. J., Morozova, O., Attiyeh, E. F., Asgharzadeh, S., Wei, J. S., Auclair, D., Carter, S. L., Cibulskis, K., Hanna, M., Kiezun, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2529 · Cited by 1,186
Welcker, M., Orian, A., Jin, J., Grim, J. A., Harper, J. W., Eisenman, R. N., & Clurman, B. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402770101 · Cited by 941
Oncogenic mutations of ALK kinase in neuroblastoma
Chen, Y., Takita, J., Choi, Y. L., Kato, M., Ohira, M., Sanada, M., Wang, L., Soda, M., Kikuchi, A., Igarashi, T., et al. (2008) · Nature · doi:10.1038/nature07399 · Cited by 916
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
Strasser, A., Harris, A. W., Bath, M. L., & Cory, S. (1990) · Nature · doi:10.1038/348331a0 · Cited by 905
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Janoueix-Lerosey, I., Lequin, D., Brugières, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., et al. (2008) · Nature · doi:10.1038/nature07398 · Cited by 894
Activating mutations in ALK provide a therapeutic target in neuroblastoma
George, R. E., Sanda, T., Hanna, M., Fröhling, S., II, W. L., Zhang, J., Ahn, Y., Zhou, W., London, W. B., McGrady, P., et al. (2008) · Nature · doi:10.1038/nature07397 · Cited by 893
Targeted expression of MYCN causes neuroblastoma in transgenic mice
Weiss, W. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.2985 · Cited by 870
Self-citationSequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Molenaar, J. J., Koster, J., Zwijnenburg, D. A., van Sluis, P., Valentijn, L. J., van der Ploeg, I., Hamdi, M., van Nes, J., Westerman, B. A., van Arkel, J., et al. (2012) · Nature · doi:10.1038/nature10910 · Cited by 870
Teitz, T., Wei, T., Valentine, M. B., Vanin, E. F., Grenet, J., Valentine, V. A., Behm, F. G., Look, A. T., Lahti, J. M., & Kidd, V. J. (2000) · Nature Medicine · doi:10.1038/75007 · Cited by 811
Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7
Yada, M., Hatakeyama, S., Kamura, T., Nishiyama, M., Tsunematsu, R., Imaki, H., Ishida, N., Okumura, F., Nakayama, K., & Nakayama, K. I. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600217 · Cited by 808
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Pugh, T. J., Weeraratne, S. D., Archer, T. C., Pomeranz Krummel, D. A., Auclair, D., Bochicchio, J., Carneiro, M. O., Carter, S. L., Cibulskis, K., Erlich, R. L., et al. (2012) · Nature · doi:10.1038/nature11329 · Cited by 750
Transposition and amplification of oncogene-related sequences in human neuroblastomas
Kohl, N. E., Kanda, N., Schreck, R. R., Bruns, G., Latt, S. A., Gilbert, F., & Alt, F. W. (1983) · Cell · doi:10.1016/0092-8674(83)90169-1 · Cited by 731
Thiele, C. J., Reynolds, C. P., & Israel, M. A. (1985) · Nature · doi:10.1038/313404a0 · Cited by 642
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
Puissant, A., Frumm, S. M., Alexe, G., Bassil, C. F., Qi, J., Chanthery, Y. H., Nekritz, E. A., Zeid, R., Gustafson, W. C., Greninger, P., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0418 · Cited by 637
Self-citationChromosome 1p and 11q Deletions and Outcome in Neuroblastoma
Attiyeh, E. F., London, W. B., Mossé, Y. P., Wang, Q., Winter, C., Khazi, D., McGrady, P. W., Seeger, R. C., Look, A. T., Shimada, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052399 · Cited by 580
Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
Otto, T., Horn, S., Brockmann, M., Eilers, U., Schüttrumpf, L., Popov, N., Kenney, A. M., Schulte, J. H., Beijersbergen, R., Christiansen, H., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.005 · Cited by 573
Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins
Stupack, D. G., Puente, X. S., Boutsaboualoy, S., Storgard, C. M., & Cheresh, D. A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200106070 · Cited by 554
Differential expression of myc family genes during murine development
Zimmerman, K. A., Yancopoulos, G. D., Collum, R. G., Smith, R. K., Kohl, N. E., Denis, K. A., Nau, M. M., Witte, O. N., Toran-Allerand, D., Gee, C. E., et al. (1986) · Nature · doi:10.1038/319780a0 · Cited by 540
Davis, A. C., Wims, M., Spotts, G. D., Hann, S. R., & Bradley, A. (1993) · Genes & Development · doi:10.1101/gad.7.4.671 · Cited by 534
Yan, H., Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou206.18 · Cited by 529
Knoepfler, P. S., Cheng, P. F., & Eisenman, R. N. (2002) · Genes & Development · doi:10.1101/gad.1021202 · Cited by 519
Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1923 · Cited by 509
Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
Lasorella, A., Noseda, M., Beyna, M., & Iavarone, A. (2000) · Nature · doi:10.1038/35036504 · Cited by 497
Kenney, A. M., Cole, M. D., & Rowitch, D. H. (2003) · Development · doi:10.1242/dev.00182 · Cited by 477
Farrell, A. S., & Sears, R. C. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014365 · Cited by 468
Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
Cheung, N.-K. V. (2012) · JAMA · doi:10.1001/jama.2012.228 · Cited by 468
Myc represses transcription through recruitment of DNA methyltransferase corepressor
Brenner, C., Deplus, R., Didelot, C., Loriot, A., Viré, E., De Smet, C., Gutierrez, A., Danovi, D., Bernard, D., Boon, T., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600509 · Cited by 445
Metastatic Sites in Stage IV and IVS Neuroblastoma Correlate With Age, Tumor Biology, and Survival
DuBois, S. G., Kalika, Y., Lukens, J. N., Brodeur, G. M., Seeger, R. C., Atkinson, J. B., Haase, G. M., Black, C. T., Perez, C., Shimada, H., et al. (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199905000-00005 · Cited by 433
Expression and function of TRK-B and BDNF in human neuroblastomas.
Nakagawara, A., Azar, C. G., Scavarda, N. J., & Brodeur, G. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.759 · Cited by 423
Sausen, M., Leary, R. J., Jones, S., Wu, J., Reynolds, C. P., Liu, X., Blackford, A., Parmigiani, G., Diaz, L. A., Papadopoulos, N., et al. (2013) · Nature Genetics · doi:10.1038/ng.2493 · Cited by 414
Promotion of direct reprogramming by transformation-deficient Myc
Nakagawa, M., Takizawa, N., Narita, M., Ichisaka, T., & Yamanaka, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009374107 · Cited by 402
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
Molenaar, J. J., Domingo-Fernández, R., Ebus, M. E., Lindner, S., Koster, J., Drabek, K., Mestdagh, P., van Sluis, P., Valentijn, L. J., van Nes, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2436 · Cited by 383
Myc influences global chromatin structure
Knoepfler, P. S., Zhang, X., Cheng, P. F., Gafken, P. R., McMahon, S. B., & Eisenman, R. N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601152 · Cited by 383
(1982) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/68.4.589 · Cited by 376
Stanton, B. R., Perkins, A. S., Tessarollo, L., Sassoon, D. A., & Parada, L. F. (1992) · Genes & Development · doi:10.1101/gad.6.12a.2235 · Cited by 372
Iavarone, A., Garg, P., Lasorella, A., Hsu, J., & Israel, M. A. (1994) · Genes & Development · doi:10.1101/gad.8.11.1270 · Cited by 367
Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
Zhu, S., Lee, J.-S., Guo, F., Shin, J., Perez-Atayde, A. R., Kutok, J. L., Rodig, S. J., Neuberg, D. S., Helman, D., Feng, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.010 · Cited by 365
Meitar, D., Crawford, S. E., Rademaker, A. W., & Cohn, S. L. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.405 · Cited by 342
N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation
Malynn, B. A., de Alboran, I. M., O'Hagan, R. C., Bronson, R., Davidson, L., DePinho, R. A., & Alt, F. W. (2000) · Genes & Development · doi:10.1101/gad.14.11.1390 · Cited by 335
The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
Berry, T., Luther, W., Bhatnagar, N., Jamin, Y., Poon, E., Sanda, T., Pei, D., Sharma, B., Vetharoy, W. R., Hallsworth, A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.001 · Cited by 326
Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene.
Charron, J., Malynn, B. A., Fisher, P., Stewart, V, Jeannotte, L., Goff, S. P., Robertson, E. J., & Alt, F. W. (1992) · Genes & Development · doi:10.1101/gad.6.12a.2248 · Cited by 323
An Animal Model of MYC-Driven Medulloblastoma
Pei, Y., Moore, C. E., Wang, J., Tewari, A. K., Eroshkin, A., Cho, Y.-J., Witt, H., Korshunov, A., Read, T.-A., Sun, J. L., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.021 · Cited by 320
Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN
Bjerke, L., Mackay, A., Nandhabalan, M., Burford, A., Jury, A., Popov, S., Bax, D. A., Carvalho, D., Taylor, K. R., Vinci, M., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0426 · Cited by 318
Kotake, Y., Cao, R., Viatour, P., Sage, J., Zhang, Y., & Xiong, Y. (2007) · Genes & Development · doi:10.1101/gad.1499407 · Cited by 311
Integrative genomics identifies LMO1 as a neuroblastoma oncogene
Wang, K., Diskin, S. J., Zhang, H., Attiyeh, E. F., Winter, C., Hou, C., Schnepp, R. W., Diamond, M., Bosse, K., Mayes, P. A., et al. (2011) · Nature · doi:10.1038/nature09609 · Cited by 310
Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity
Laurenti, E., Varnum-Finney, B., Wilson, A., Ferrero, I., Blanco-Bose, W. E., Ehninger, A., Knoepfler, P. S., Cheng, P.-F., MacDonald, H. R., Eisenman, R. N., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.005 · Cited by 305
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
Capasso, M., Devoto, M., Hou, C., Asgharzadeh, S., Glessner, J. T., Attiyeh, E. F., Mosse, Y. P., Kim, C., Diskin, S. J., Cole, K. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.374 · Cited by 305
A Mouse Model of the Most Aggressive Subgroup of Human Medulloblastoma
Kawauchi, D., Robinson, G., Uziel, T., Gibson, P., Rehg, J., Gao, C., Finkelstein, D., Qu, C., Pounds, S., Ellison, D. W., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.023 · Cited by 305
Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture
Schwab, M., Varmus, H. E., & Bishop, J. M. (1985) · Nature · doi:10.1038/316160a0 · Cited by 288
Au, S. L.-K., Wong, C. C.-L., Lee, J. M.-F., Fan, D. N.-Y., Tsang, F. H., Ng, I. O.-L., & Wong, C.-M. (2012) · Hepatology · doi:10.1002/hep.25679 · Cited by 287
De Brouwer, S., De Preter, K., Kumps, C., Zabrocki, P., Porcu, M., Westerhout, E. M., Lakeman, A., Vandesompele, J., Hoebeeck, J., Van Maerken, T., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2660 · Cited by 279
Potentiation of neuroblastoma metastasis by loss of caspase-8
Stupack, D. G., Teitz, T., Potter, M. D., Mikolon, D., Houghton, P. J., Kidd, V. J., Lahti, J. M., & Cheresh, D. A. (2006) · Nature · doi:10.1038/nature04323 · Cited by 277
Human N-myc is closely related in organization and nucleotide sequence to c-myc
Kohl, N. E., Legouy, E., DePinho, R. A., Nisen, P. D., Smith, R. K., Gee, C. E., & Alt, F. W. (1986) · Nature · doi:10.1038/319073a0 · Cited by 274
Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells
Valsesia-Wittmann, S., Magdeleine, M., Dupasquier, S., Garin, E., Jallas, A.-C., Combaret, V., Krause, A., Leissner, P., & Puisieux, A. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.033 · Cited by 270
Eggert, A., Grotzer, M. A., Zuzak, T. J., Wiewrodt, B. R., Ho, R., Ikegaki, N., & Brodeur, G. M. (2001) · PubMed · Cited by 267
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
Diskin, S. J., Capasso, M., Schnepp, R. W., Cole, K. A., Attiyeh, E. F., Hou, C., Diamond, M., Carpenter, E. L., Winter, C., Lee, H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2387 · Cited by 266
Westermann, F., Muth, D., Benner, A., Bauer, T., Henrich, K.-O., Oberthuer, A., Brors, B., Beissbarth, T., Vandesompele, J., Pattyn, F., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-10-r150 · Cited by 264
Casaccia-Bonnefil, P., Tikoo, R., Kiyokawa, H., Friedrich, V., Chao, M. V., & Koff, A. (1997) · Genes & Development · doi:10.1101/gad.11.18.2335 · Cited by 252
Cole, K. A., Huggins, J., Laquaglia, M., Hulderman, C. E., Russell, M. R., Bosse, K., Diskin, S. J., Attiyeh, E. F., Sennett, R., Norris, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012351108 · Cited by 249
Id2 Specifically Alters Regulation of the Cell Cycle by Tumor Suppressor Proteins
Lasorella, A., Iavarone, A., & Israel, M. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.2570 · Cited by 241
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma
Slack, A., Chen, Z., Tonelli, R., Pule, M., Hunt, L., Pession, A., & Shohet, J. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405495102 · Cited by 233
Carén, H., Kryh, H., Nethander, M., Sjöberg, R.-M., Träger, C., Nilsson, S., Abrahamsson, J., Kogner, P., & Martinsson, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910684107 · Cited by 232
Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Ho, R., Eggert, A., Hishiki, T., Minturn, J. E., Ikegaki, N., Foster, P., Camoratto, A. M., Evans, A. E., & Brodeur, G. M. (2002) · PubMed · Cited by 228
Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo.
Pulverer, B., Fisher, C., Vousden, K. H., Littlewood, T. D., Evan, G. I., & Woodgett, J. R. (1994) · PubMed · Cited by 228
Seth, A., Alvarez, E., Gupta, S., & Davis, R. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54312-x · Cited by 225
Blasina, A., Hallin, J., Chen, E., Arango, M. E., Kraynov, E., Register, J., Grant, S., Ninkovic, S., Chen, P., Nichols, T., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2391 · Cited by 223
Lutterbach, B., & Hann, S. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5510 · Cited by 220
Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC
Swartling, F. J., Savov, V., Persson, A. I., Chen, J., Hackett, C. S., Northcott, P. A., Grimmer, M. R., Lau, J., Chesler, L., Perry, A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.012 · Cited by 215
Self-citationHelland, Å., Anglesio, M. S., George, J., Cowin, P. A., Johnstone, C. N., House, C. M., Sheppard, K. E., Etemadmoghadam, D., Melnyk, N., Rustgi, A. K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018064 · Cited by 215
myc maintains embryonic stem cell pluripotency and self-renewal
Varlakhanova, N. V., Cotterman, R. F., deVries, W. N., Morgan, J., Donahue, L. R., Murray, S., Knowles, B. B., & Knoepfler, P. S. (2010) · Differentiation · doi:10.1016/j.diff.2010.05.001 · Cited by 205
Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse
Sawai, S., Shimono, A., Wakamatsu, Y., Palmes, C., Hanaoka, K., & Kondoh, H. (1993) · Development · doi:10.1242/dev.117.4.1445 · Cited by 204
Myc proteins as therapeutic targets
Gustafson, W. C., & Weiss, W. A. (2010) · Oncogene · doi:10.1038/onc.2009.512 · Cited by 204
Self-citationChesler, L., Schlieve, C., Goldenberg, D. D., Kenney, A., Kim, G., McMillan, A., Matthay, K. K., Rowitch, D., & Weiss, W. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2769 · Cited by 202
Self-citationSwarbrick, A., Woods, S. L., Shaw, A., Balakrishnan, A., Phua, Y., Nguyen, A., Chanthery, Y., Lim, L., Ashton, L. J., Judson, R. L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2227 · Cited by 201
Self-citationNucleotide sequence of the human N-myc gene.
Stanton, L. W., Schwab, M., & Bishop, J. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1772 · Cited by 187
Promising Therapeutic Targets in Neuroblastoma
Matthay, K. K., George, R. E., & Yu, A. L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1939 · Cited by 187
N-myc can cooperate with ras to transform normal cells in culture.
Yancopoulos, G. D., Nisen, P. D., Tesfaye, A., Kohl, N. E., Goldfarb, M. P., & Alt, F. W. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.16.5455 · Cited by 184
Plantaz, D., Mohapatra, G., Matthay, K. K., Pellarin, M., Seeger, R. C., & Feuerstein, B. G. (1997) · Europe PMC (PubMed Central) · Cited by 181
Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
Heukamp, L. C., Thor, T., Schramm, A., De Preter, K., Kumps, C., De Wilde, B., Odersky, A., Peifer, M., Lindner, S., Spruessel, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003967 · Cited by 181
Role of MYC in medulloblastoma
Roussel, M. F., & Robinson, G. W. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014308 · Cited by 180
Targeting ALK in neuroblastoma—preclinical and clinical advancements
Carpenter, E. L., & Mossé, Y. P. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.72 · Cited by 177
Johnsen, J. I., Segerström, L., Orrego, A., Elfman, L., Henriksson, M., Kågedal, B., Eksborg, S., Sveinbjörnsson, B., & Kogner, P. (2008) · Oncogene · doi:10.1038/sj.onc.1210938 · Cited by 171
Wakamatsu, Y., Watanabe, Y., Nakamura, H., & Kondoh, H. (1997) · Development · doi:10.1242/dev.124.10.1953 · Cited by 169
Nguyễn, L. B., Diskin, S. J., Capasso, M., Wang, K., Diamond, M. A., Glessner, J., Kim, C., Attiyeh, E. F., Mosse, Y. P., Cole, K., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002026 · Cited by 165
Zhao, X., D' Arca, D., Lim, W. K., Brahmachary, M., Carro, M. S., Ludwig, T., Cardo, C. C., Guillemot, F., Aldape, K., Califano, A., et al. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.07.009 · Cited by 161
Hatton, B. A., Knoepfler, P. S., Kenney, A. M., Rowitch, D. H., de Alborán, I. M., Olson, J. M., & Eisenman, R. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1621 · Cited by 154
Marshall, G. M., Liu, P. Y., Gherardi, S., Scarlett, C. J., Bedalov, A., Xu, N., Iraci, N., Valli, E., Ling, D., Thomas, W. D., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002135 · Cited by 153
Sjostrom, S. K., Finn, G., Hahn, W. C., Rowitch, D. H., & Kenney, A. M. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.07.014 · Cited by 150
Lovén, J., Zinin, N., Wahlström, T., Müller, I., Brodin, P., Fredlund, E., Ribacke, U., Pivarcsi, A., Påhlman, S., & Arsenian‐Henriksson, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913517107 · Cited by 139
p53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma
Chen, L., Iraci, N., Gherardi, S., Gamble, L. D., Wood, K. M., Perini, G., Lunec, J., & Tweddle, D. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2598 · Cited by 139
Lasorella, A., Boldrini, R., Dominici, C., Donfrancesco, A., Yokota, Y., Inserra, A., & Iavarone, A. (2002) · PubMed · Cited by 139
Caspase-8 Association with the Focal Adhesion Complex Promotes Tumor Cell Migration and Metastasis
Barbero, S., Mielgo, A., Torres, V. A., Teitz, T., Shields, D. J., Mikolon, D., Bogyo, M. S., Barilà, D., Lahti, J. M., Schlaepfer, D. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3937 · Cited by 137
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma
Song, L., Ara, T., Wu, H., Woo, C., Reynolds, C. P., Seeger, R. C., DeClerck, Y. A., Thiele, C. J., Sposto, R., & Metelitsa, L. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30751 · Cited by 123
Roles for MYC in the Establishment and Maintenance of PluripotencyPreprint
Chappell, J., & Dalton, S. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014381 · Cited by 123
Schönherr, C., Ruuth, K., Kamaraj, S., Wang, C.-L., Yang, H.-L., Combaret, V., Djos, A., Martinsson, T., Christensen, J. G., Palmer, R. H., et al. (2012) · Oncogene · doi:10.1038/onc.2012.12 · Cited by 122
Capasso, M., Diskin, S. J., Totaro, F., Longo, L., Mariano, M. D., Russo, R., Cimmino, F., Hakonarson, H. H., Tonini, G. P., Devoto, M., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs380 · Cited by 115
The Role of MIZ-1 in MYC-Dependent TumorigenesisPreprint
Wiese, K. E., Walz, S., von Eyß, B., Wolf, E., Athineos, D., Sansom, O. J., & Eilers, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014290 · Cited by 114
Rosenbaum, H., Webb, E., Adams, J. M., Cory, S., & Harris, A. W. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03435.x · Cited by 110
Liu, T., Tee, A. E., Porro, A., Smith, S. A., Dwarte, T. M., Liu, P. Y., Iraci, N., Sekyere, E. O., Haber, M., Norris, M. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705524104 · Cited by 110
Mossé, Y. P., Diskin, S. J., Wasserman, N. F., Rinaldi, K., Attiyeh, E. F., Cole, K. A., Jagannathan, J., Bhambhani, K., Winter, C. L., & Maris, J. M. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20477 · Cited by 110
Neuroblastoma: Biology and staging
Mueller, S., & Matthay, K. K. (2009) · Current Oncology Reports · doi:10.1007/s11912-009-0059-6 · Cited by 109
Genome Recognition by MYCPreprint
Sabò, A., & Amati, B. B. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014191 · Cited by 108
Burkhart, C. A., Cheng, A. J., Madafiglio, J., Kavallaris, M., Mili, M., Marshall, G. M., Weiss, W. A., Khachigian, L. M., Norris, M. D., & Haber, M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg045 · Cited by 108
Self-citationTranscriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects
Marshall, G. M., Gherardi, S., Xu, N., Neiron, Z., Trahair, T. N., Scarlett, C. J., Chang, D. K.-F., Liu, P. Y., Jankowski, K., Iraci, N., et al. (2010) · Oncogene · doi:10.1038/onc.2010.332 · Cited by 105
Hartl, M., Mitterstiller, A., Valovka, T., Breuker, K., Hobmayer, B., & Bister, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911060107 · Cited by 104
Schulte, J. H., Lindner, S., Bohrer, A., et al. (2012) · Oncogene · doi:10.1038/onc.2012.106 · Cited by 103
A conserved element in Myc that negatively regulates its proapoptotic activity
Herbst, A., Hemann, M. T., Tworkowski, K. A., Salghetti, S. E., Lowe, S. W., & Tansey, W. P. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400333 · Cited by 100
Iraci, N., Diolaiti, D., Papa, A., Porro, A., Valli, E., Gherardi, S., Herold, S., Eilers, M., Bernardoni, R., Valle, G. D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2627 · Cited by 100
Cotterman, R. F., & Knoepfler, P. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005799 · Cited by 97
N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma
Kang, J., Rychahou, P. G., Ishola, T., Mourot, J. M., Evers, B. M., & Chung, D. H. (2008) · Oncogene · doi:10.1038/onc.2008.15 · Cited by 97
p53 regulates FAK expression in human tumor cells
Golubovskaya, V., Finch, R., Kweh, F. A., Massoll, N. A., Campbell‐Thompson, M., Wallace, M. R., & Cance, W. G. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20395 · Cited by 97
Physical Interaction between MYCN Oncogene and Polycomb Repressive Complex 2 (PRC2) in Neuroblastoma
Corvetta, D., Chayka, O., Gherardi, S., D’Acunto, C. W., Cantilena, S., Valli, E., Piotrowska, I., Perini, G., & Sala, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.454280 · Cited by 92
myc gene amplification and expression in primary human neuroblastoma.
Slavc, I., Ellenbogen, R. G., Jung, W. H., Vawter, G. F., Kretschmar, C. S., Grier, H. E., & Korf, B. R. (1990) · PubMed · Cited by 90
MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63
Gamble, L. D., Kees, U. R., Tweddle, D. A., & Lunec, J. (2011) · Oncogene · doi:10.1038/onc.2011.270 · Cited by 87
Ochiai, H., Takenobu, H., Nakagawa, A., Yamaguchi, Y., Kimura, M., Ohira, M., Okimoto, Y., Fujimura, Y., Koseki, H., Kohno, Y., et al. (2010) · Oncogene · doi:10.1038/onc.2010.22 · Cited by 85
Faisal, A., Vaughan, L. S., Bavetsias, V., Sun, C., Atrash, B., Avery, S., Jamin, Y., Robinson, S. P., Workman, P., Blagg, J., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0333 · Cited by 85
Paracrine Signaling Through MYCN Enhances Tumor-Vascular Interactions in Neuroblastoma
Chanthery, Y. H., Gustafson, W. C., Itsara, M., Persson, A. I., Hackett, C. S., Grimmer, M., Charron, E., Yakovenko, S., Kim, G., Matthay, K. K., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002977 · Cited by 84
Self-citationValentijn, L. J., Koppen, A., van Asperen, R., Root, H., Haneveld, F., & Versteeg, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2469 · Cited by 83
Huang, R., Cheung, N. V., Vider, J., Cheung, I. Y., Gerald, W. L., Tickoo, S. K., Holland, E. C., & Blasberg, R. G. (2011) · The FASEB Journal · doi:10.1096/fj.11-185033 · Cited by 82
Elson, A., Deng, C., Campos-Torres, J., Donehower, L. A., & Leder, P. (1995) · PubMed · Cited by 79
Suppression of MYC by high expression of NMYC in human neuroblastoma cells
Breit, S., & Schwab, M. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490240105 · Cited by 79
MDM2 regulates MYCN mRNA stabilization and translation in human neuroblastoma cells
Gu, L., Zhang, H., He, J., Li, J., Huang, M. J., & Zhou, M. (2011) · Oncogene · doi:10.1038/onc.2011.343 · Cited by 77
Self-citationDistinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors
Banelli, B., Gelvi, I., Vinci, A. D., Scaruffi, P., Casciano, I., Allemanni, G., Bonassi, S., Tonini, G. P., & Romani, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208722 · Cited by 76
Shioda, N., Beppu, H., Fukuda, T., Li, E., Kitajima, I., & Fukunaga, K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4816-10.2011 · Cited by 73
Ciani, E., Severi, S., Contestabile, A., Bartesaghi, R., & Contestabile, A. (2004) · Journal of Cell Science · doi:10.1242/jcs.01348 · Cited by 71
Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis
Teitz, T., Inoue, M., Valentine, M. B., Zhu, K., Rehg, J. E., Zhao, W. M., Finkelstein, D., Wang, Y., Johnson, M. D., Calabrese, C. R., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2681 · Cited by 70
Self-citationGogolin, S., Ehemann, V., Becker, G., Brueckner, L. M., Dreidax, D., Bannert, S., Nolte, I. J. A., Savelyeva, L., Bell, E., & Westermann, F. (2013) · Cell Cycle · doi:10.4161/cc.24091 · Cited by 69
Chemotherapy-Induced Apoptosis in a Transgenic Model of Neuroblastoma Proceeds Through p53 Induction
Chesler, L., Goldenberg, D., Collins, R., Grimmer, M., Kim, G., Tihan, T., Nguyen, K. N., Yakovenko, S., Matthay, K. K., & Weiss, W. A. (2008) · Neoplasia · doi:10.1593/neo.08778 · Cited by 68
Self-citationCUL7 Is a Novel Antiapoptotic Oncogene
Kim, S. S., Shago, M., Kaustov, L., Boutros, P. C., Clendening, J. W., Sheng, Y., Trentin, G. A., Baršytė-Lovejoy, D., Mao, D. Y. L., Kay, R. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0644 · Cited by 68
N-myc and Noncoding RNAs in Neuroblastoma
Buechner, J., & Einvik, C. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0244 · Cited by 68
Aberrant methylation of multiple genes in neuroblastic tumours
González‐Gómez, P., Bello, M. J., Lomas, J. S., Arjona, D., Alonso, M. E., Amiñoso, C., Lopez-Marín, I., Anselmo, N. P., Sarasa, J. L., Gutierrez, M., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00312-5 · Cited by 67
Evidence of asymmetric cell division and centrosome inheritance in human neuroblastoma cells
Izumi, H., & Kaneko, Y. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205525109 · Cited by 67
Hatzi, E. G., Murphy, C., Zoephel, A., Rasmussen, H., Morbidelli, L., Ahorn, H., Kunisada, K., Tontsch, U., Klenk, M., Yamauchi‐Takihara, K., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205440 · Cited by 67
Fuente, R. D. L., Baumann, C., & Viveiros, M. M. (2011) · Reproduction · doi:10.1530/rep-10-0380 · Cited by 65
Disruption of Cooperation Between Ras and MycN in Human Neuroblastoma Cells Promotes Growth Arrest
Yaari, S., Jacob‐Hirsch, J., Amariglio, N., Haklai, R., Rechavi, G., & Kloog, Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2071 · Cited by 65
Caron, H. N., Spieker, N., Godfried, M. B., Veenstra, M., Sluis, P. V., de Kraker, J., Voûte, P. A., & Versteeg, R. (2000) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(200102)30:2<168::aid-gcc1072>3.0.co;2-e · Cited by 61
Zhang, C., Yan, Z., Painter, C. L., Zhang, Q., Chen, E., Arango, M. E., Kuszpit, K. K., Zasadny, K. R., Hallin, M. E., Hallin, J. F., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3272 · Cited by 60
Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation
Koppen, A., Ait‐Aissa, R., Hopman, S. M. J., Köster, J., Haneveld, F., Versteeg, R., & Valentijn, L. J. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.06.011 · Cited by 59
Han, S., Wada, R. K., & Sidell, N. (2001) · PubMed · Cited by 59
Identification of ALK as the Major Familial Neuroblastoma Predisposition Gene
Arceci, R. J. (2009) · Yearbook of Oncology · doi:10.1016/s1040-1741(09)79344-3 · Cited by 59
Fotsis, T., Breit, S., Lutz, W., Rössler, J. K., Hatzi, E. G., Schwab, M., & Schweigerer, L. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00575.x · Cited by 58
N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells
Noujaim, D. L., van Golen, C. M., van Golen, K. L., Grauman, A., & Feldman, E. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205552 · Cited by 58
Cell Cycle Regulation Targets of MYCN Identified by Gene Expression Microarrays
Bell, E., Lunec, J., & Tweddle, D. A. (2007) · Cell Cycle · doi:10.4161/cc.6.10.4222 · Cited by 57
Transcriptional Repression of SKP2 Is Impaired in MYCN -Amplified Neuroblastoma
Muth, D., Ghazaryan, S., Eckerle, I., Beckett, E., Pöhler, C., Batzler, J., Beisel, C., Gogolin, S., Fischer, M., Henrich, K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1245 · Cited by 56
Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma
Koppen, A., Ait‐Aissa, R., Köster, J., Sluis, P. V., Øra, I., Caron, H. N., Volckmann, R., Versteeg, R., & Valentijn, L. J. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.07.024 · Cited by 54
FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma
Megison, M. L., Stewart, J. E., Nabers, H. C., et al. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9560-7 · Cited by 54
Raschellà, G., Cesi, V., Amendola, R., Negroni, A., Tanno, B., Altavista, P., Tonini, G. P., Bernardi, B. D., & Calabretta, B. (1999) · PubMed · Cited by 52
CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells
Valli, E., Trazzi, S., Fuchs, C., Erriquez, D., Bartesaghi, R., Perini, G., & Ciani, E. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.08.001 · Cited by 49
van Golen, C. M., Soules, M. E., Grauman, A., & Feldman, E. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206362 · Cited by 43
Meehan, M., Parthasarathi, L., Moran, N. M., Jefferies, C. A., Foley, N. H., Lazzari, E., Murphy, D. B., Ryan, J., Ortiz, B., Fabius, A. W. M., et al. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-6 · Cited by 43
Addiction of MYCN Amplified Tumours to B-MYB Underscores a Reciprocal Regulatory Loop
Gualdrini, F., Corvetta, D., Cantilena, S., Chayka, O., Tanno, B., Raschellà, G., & Sala, A. (2010) · Oncotarget · doi:10.18632/oncotarget.138 · Cited by 41
N‐myc oncogene overexpression down‐regulates leukemia inhibitory factor in neuroblastoma
Hatzi, E. G., Murphy, C., Zoephel, A., Ahorn, H., Tontsch, U., Bamberger, A., Yamauchi‐Takihara, K., Schweigerer, L., & Fotsis, T. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03066.x · Cited by 35
Reddy, C. D., Patti, R., Guttapalli, A. N., et al. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20629 · Cited by 31
The effect of N-myc amplification and expression on invasiveness of neuroblastoma cells
Zaizen, Y., Taniguchi, S., Noguchi, S., & Suita, S. (1993) · Journal of Pediatric Surgery · doi:10.1016/0022-3468(93)90321-b · Cited by 30
NLRR1 Enhances EGF-Mediated MYCN Induction in Neuroblastoma and Accelerates Tumor Growth In Vivo
Hossain, S., Takatori, A., Nakamura, Y., Suenaga, Y., Kamijo, T., & Nakagawara, A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0943 · Cited by 30
Regulation of Signaling by Protein-Tyrosine Phosphatases: Potential Roles in the Nervous System
Arregui, C. O., Balsamo, J., & Lilien, J. E. (2000) · Neurochemical Research · doi:10.1023/a:1007595617447 · Cited by 25
Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1
Hiyama, E., Hiyama, K., Ohtsu, K., Yamaoka, H., Fukuba, I., Matsuura, Y., & Yokoyama, T. (2001) · Medical and Pediatric Oncology · doi:10.1002/1096-911x(20010101)36:1<67::aid-mpo1017>3.0.co;2-s · Cited by 23
Komuro, H., Valentine, M. B., Rowe, S. T., et al. (1998) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(98)90612-1 · Cited by 21
DeWitt, J., Ochoa, V., Urschitz, J., Elston, M., Moisyadi, S., & Nishi, R. (2013) · Oncogene · doi:10.1038/onc.2013.39 · Cited by 21
Matsumoto, M., Akiyama, T., Miyatake, S., et al. (1989) · Acta Neuropathologica · doi:10.1007/bf00294382 · Cited by 12
Functional Analysis of the Putative Tumor SuppressorPTPRDin Neuroblastoma Cells
Clark, O., Schmidt, F., Coles, C. H., Tchetchelnitski, V., & Stoker, A. W. (2012) · Cancer Investigation · doi:10.3109/07357907.2012.675383 · Cited by 11
Cited by
Matthay, K. K., Maris, J. M., Schleiermacher, G., Nakagawara, A., Mackall, C. L., Diller, L., & Weiss, W. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.78 · Cited by 1,419
Self-citationThe bright side of dark matter: lncRNAs in cancer
Evans, J. R., Feng, F. Y., & Chinnaiyan, A. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84421 · Cited by 451
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Christensen, C. L., Kwiatkowski, N., Abraham, B. J., Carretero, J., Al-Shahrour, F., Zhang, T., Chipumuro, E., Herter-Sprie, G. S., Akbay, E. A., Altabef, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.019 · Cited by 439
An Overview of MYC and Its Interactome
Conacci-Sorrell, M., McFerrin, L., & Eisenman, R. N. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014357 · Cited by 408
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells
Lee, J. K., Phillips, J. W., Smith, B. A., Park, J. W., Stoyanova, T., McCaffrey, E. F., Baertsch, R., Sokolov, A., Meyerowitz, J. G., Mathis, C., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.001 · Cited by 407
Metadata
- Authors
- Huang, M., & Weiss, W. A.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2013-10-01
- Volume
- 3
- Issue
- 10
- Pages
- a014415-a014415
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2098282574
- Cited by
- 647
- References
- 173
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.